Methylphenidate and/or a nursing telephone intervention for fatigue in patients with advanced cancer: A randomized, placebo-controlled, phase II trial

Journal of Clinical Oncology

Volumn 31, Issue 19, 2013, Pages 2421-2427

  Bruera, Eduardo ^a   Yennurajalingam, Sriram ^a   Palmer, J Lynn ^a   Perez Cruz, Pedro E ^a,c   Frisbee Hume, Susan ^a   Allo, Julio A ^a   Williams, Janet L ^a   Cohen, Marlene Z ^b  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^c PONTIFICIA UNIVERSIDAD CATÓLICA DE CHILE   (Chile)

Author keywords

[No Author keywords available]

Indexed keywords

METHYLPHENIDATE; PLACEBO; CENTRAL STIMULANT AGENT; DOPAMINE UPTAKE INHIBITOR;

ADULT; ADVANCED CANCER; AGED; ANOREXIA; ANXIETY; ANXIETY DISORDER; APPETITE; ARTICLE; CANCER FATIGUE; CANCER PAIN; CONTROLLED STUDY; DEPRESSION; DROWSINESS; DYSPNEA; EDMONTON SYMPTOM ASSESSMENT SCALE; FAINTNESS; FEMALE; FLU LIKE SYNDROME; FUNCTIONAL ASSESSMENT; FUNCTIONAL ASSESSMENT OF CHRONIC ILLNESS THERAPY; HUMAN; HYPERTENSION; INSOMNIA; MAJOR CLINICAL STUDY; MALE; NAUSEA; PAIN; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SLEEP; SLURRED SPEECH; SYMPTOM ASSESSMENT; TACHYCARDIA; TELENURSING; TREATMENT OUTCOME; WELLBEING; CANCER STAGING; CONTROLLED CLINICAL TRIAL; COUNSELING; DRUG EFFECT; FATIGUE; MIDDLE AGED; NEOPLASM; NURSING; ORAL DRUG ADMINISTRATION; PATHOLOGY; SLEEP STAGE; TELEPHONE; TREATMENT FAILURE;

ADMINISTRATION, ORAL; ADULT; AGED; CENTRAL NERVOUS SYSTEM STIMULANTS; COUNSELING; DEPRESSION; DOPAMINE UPTAKE INHIBITORS; FATIGUE; FEMALE; HUMANS; MALE; METHYLPHENIDATE; MIDDLE AGED; NEOPLASM STAGING; NEOPLASMS; SLEEP STAGES; TELEPHONE; TREATMENT FAILURE;

EID: 84883110804     PISSN: 0732183X     EISSN: 15277755     Source Type: Journal    
DOI: 10.1200/JCO.2012.45.3696     Document Type: Article

References (38)

1. Yennurajalingam S, Bruera E: Palliative management of fatigue at the close of life: “It feels like my body is just worn out.” JAMA 297:295-304, 2007
2. Lawrence DP, Kupelnick B, Miller K, et al: Evidence report on the occurrence, assessment, and treatment of fatigue in cancer patients. J Natl Cancer Inst Monogr 2004:40-50, 2004
3. Piper BF, Cella D: Cancer-related fatigue: Definitions and clinical subtypes. J Natl Compr Canc Netw 8:958-966, 2010
4. Minton O, Richardson A, Sharpe M, et al: Drug therapy for the management of cancer-related fatigue. Cochrane Database Syst Rev 7:CD006704, 2010
5. Minton O, Richardson A, Sharpe M, et al: Psychostimulants for the management of cancer-related fatigue: A systematic review and meta-analysis. J Pain Symptom Manage 41:761-767, 2011
6. Peuckmann V, Elsner F, Krumm N, et al: Pharmacological treatments for fatigue associated with palliative care. Cochrane Database Syst Rev 11:CD006788, 2010
7. Berger AM, Abernethy AP, Atkinson A, et al: Cancer-related fatigue. J Natl Compr Canc Netw 8:904-931, 2010
8. Bruera E, Driver L, Barnes EA, et al: Patient-controlled methylphenidate for the management of fatigue in patients with advanced cancer: A preliminary report. J Clin Oncol 21:4439-4443, 2003
9. Bruera E, Valero V, Driver L, et al: Patient-controlled methylphenidate for cancer fatigue: A double-blind, randomized, placebo-controlled trial. J Clin Oncol 24:2073-2078, 2006
10. Butler JM Jr, Case LD, Atkins J, et al: A phase III, double-blind, placebo-controlled prospective randomized clinical trial of d-threo-methylphenidate HCl in brain tumor patients receiving radiation therapy. Int J Radiat Oncol Biol Phys 69:1496-1501, 2007
11. Lower EE, Fleishman S, Cooper A, et al: Efficacy of dexmethylphenidate for the treatment of fatigue after cancer chemotherapy: A randomized clinical trial. J Pain Symptom Manage 38:650-662, 2009
12. Mar Fan HG, Clemons M, Xu W, et al: A randomised, placebo-controlled, double-blind trial of the effects of d-methylphenidate on fatigue and cognitive dysfunction in women undergoing adjuvant chemotherapy for breast cancer. Support Care Cancer 16:577-583, 2008
13. Auret KA, Schug SA, Bremner AP, et al: A randomized, double-blind, placebo-controlled trial assessing the impact of dexamphetamine on fatigue in patients with advanced cancer. J Pain Symptom Manage 37:613-621, 2009
14. Cusack M, Taylor C: A literature review of the potential of telephone follow-up in colorectal cancer. J Clin Nurs 19:2394-2405, 2010
15. Beney J, Devine EB, Chow V, et al: Effect of telephone follow-up on the physical well-being dimension of quality of life in patients with cancer. Pharmacotherapy 22:1301-1311, 2002
16. Cox K, Wilson E: Follow-up for people with cancer: Nurse-led services and telephone interventions. J Adv Nurs 43:51-61, 2003
17. Zhang JE, Wong FK, You LM, et al: A qualitative study exploring the nurse telephone follow-up of patients returning home with a colostomy. J Clin Nurs 21:1407-1415, 2012
18. Salonen P, Tarkka MT, Kellokumpu-Lehtinen PL, et al: Telephone intervention and quality of life in patients with breast cancer. Cancer Nurs 32:177-190, 2009
19. Yesilbalkan OU, Karadakovan A, Göker E: The effectiveness of nursing education as an intervention to decrease fatigue in Turkish patients receiving chemotherapy. Oncol Nurs Forum 36:E215–E222, 2009
20. Godino C, Jodar L, Durán A, et al: Nursing education as an intervention to decrease fatigue perception in oncology patients. Eur J Oncol Nurs 10:150-155, 2006
21. Badger T, Segrin C, Meek P, et al: Telephone interpersonal counseling with women with breast cancer: Symptom management and quality of life. Oncol Nurs Forum 32:273-279, 2005
22. Yates P, Aranda S, Hargraves M, et al: Randomized controlled trial of an educational intervention for managing fatigue in women receiving adjuvant chemotherapy for early-stage breast cancer. J Clin Oncol 23:6027-6036, 2005
23. Given B, Given CW, McCorkle R, et al: Pain and fatigue management: Results of a nursing randomized clinical trial. Oncol Nurs Forum 29:949-956, 2002
24. Cella DF, Tulsky DS, Gray G, et al: The Functional Assessment of Cancer Therapy scale: Development and validation of the general measure. J Clin Oncol 11:570-579, 1993
25. Bruera E, Kuehn N, Miller MJ, et al: The Edmonton Symptom Assessment System (ESAS): A simple method for the assessment of palliative care patients. J Palliat Care 7:6-9, 1991
26. Cleeland CS, Mendoza TR, Wang XS, et al: Assessing symptom distress in cancer patients: The M.D. Anderson Symptom Inventory. Cancer 89: 1634-1646, 2000
27. Bruera E, El Osta B, Valero V, et al: Donepezil for cancer fatigue: A double-blind, randomized, placebo-controlled trial. J Clin Oncol 25:3475-3481, 2007
28. Cella D, Eton DT, Lai JS, et al: Combining anchor and distribution-based methods to derive minimal clinically important differences on the Functional Assessment of Cancer Therapy (FACT) anemia and fatigue scales. J Pain Symptom Manage 24:547-561, 2002
29. Carvajal A, Centeno C, Watson R, et al: A comprehensive study of psychometric properties of the Edmonton Symptom Assessment System (ESAS) in Spanish advanced cancer patients. Eur J Cancer 47:1863-1872, 2011
30. Chang VT, Hwang SS, Feuerman M: Validation of the Edmonton Symptom Assessment Scale. Cancer 88:2164-2171, 2000
31. Johnston M, Pollard B, Hennessey P: Construct validation of the hospital anxiety and depression scale with clinical populations. J Psychosom Res 48:579-584, 2000
32. Buysse DJ, Reynolds CF 3rd, Monk TH, et al: The Pittsburgh Sleep Quality Index: A new instrument for psychiatric practice and research. Psychiatry Res 28:193-213, 1989
33. Moraska AR, Sood A, Dakhil SR, et al: Phase III, randomized, double-blind, placebo-controlled study of long-acting methylphenidate for cancer-related fatigue: North Central Cancer Treatment Group NCCTG-N05C7 trial. J Clin Oncol 28:3673-3679, 2010
34. Bruera E, Chadwick S, Brenneis C, et al: Methylphenidate associated with narcotics for the treatment of cancer pain. Cancer Treat Rep 71:67-70, 1987
35. Bruera E, Miller MJ, Macmillan K, et al: Neu-ropsychological effects of methylphenidate in patients receiving a continuous infusion of narcotics for cancer pain. Pain 48:163-166, 1992
36. Kelly DF, Faught WJ, Holmes LA: Ovarian cancer treatment: The benefit of patient telephone follow-up post-chemotherapy. Can Oncol Nurs J 9:175-178, 1999
37. Poncia HD, Ryan J, Carver M: Next day telephone follow up of the elderly: A needs assessment and critical incident monitoring tool for the accident and emergency department. J Accid Emerg Med 17:337-340, 2000
38. de la Cruz M, Hui D, Parsons HA, et al: Placebo and nocebo effects in randomized double-blind clinical trials of agents for the therapy for fatigue in patients with advanced cancer. Cancer 116:766-774, 2010